These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32042922)

  • 1. Neuropathologic description of
    Keith JL; Swinkin E; Gao A; Alminawi S; Zhang M; McGoldrick P; McKeever P; Robertson J; Rogaeva E; Zinman L
    Neurol Genet; 2020 Feb; 6(1):e394. PubMed ID: 32042922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
    Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
    Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
    Sun X; Song J; Huang H; Chen H; Qian K
    Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
    Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
    Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
    Shammas MK; Huang TH; Narendra DP
    Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early death of ALS-linked CHCHD10-R15L transgenic mice with central nervous system, skeletal muscle, and cardiac pathology.
    Ryan ÉB; Yan J; Miller N; Dayanidhi S; Ma YC; Deng HX; Siddique T
    iScience; 2021 Feb; 24(2):102061. PubMed ID: 33659869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHCHD10 variants in amyotrophic lateral sclerosis: Where is the evidence?
    Project MinE ALS Sequencing Consortium
    Ann Neurol; 2018 Jul; 84(1):110-116. PubMed ID: 30014597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
    Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA
    Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
    Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore DG; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
    Brain; 2014 Aug; 137(Pt 8):2329-45. PubMed ID: 24934289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS-like phenotype and Complex I deficiency independent of the mitochondrial integrated stress response.
    Petel Légaré V; Rampal CJ; Gurberg TJN; Aaltonen MJ; Janer A; Zinman L; Shoubridge EA; Armstrong GAB
    Dev Neurobiol; 2023 Jan; 83(1-2):54-69. PubMed ID: 36799027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p.N345K mutation in TARDBP in a patient with familial amyotrophic lateral sclerosis: An autopsy case.
    Takeda T; Iijima M; Shimizu Y; Yoshizawa H; Miyashiro M; Onizuka H; Yamamoto T; Nishiyama A; Suzuki N; Aoki M; Shibata N; Kitagawa K
    Neuropathology; 2019 Aug; 39(4):286-293. PubMed ID: 31124595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation.
    Kreiter N; Pal A; Lojewski X; Corcia P; Naujock M; Reinhardt P; Sterneckert J; Petri S; Wegner F; Storch A; Hermann A
    Neurobiol Dis; 2018 Jul; 115():167-181. PubMed ID: 29630989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHCHD10
    Genin EC; di Borgo PP; Lorivel T; Hugues S; Farinelli M; Mauri-Crouzet A; Lespinasse F; Godin L; Paquis-Flucklinger V; Petit-Paitel A
    Neurobiol Dis; 2024 Jun; 195():106498. PubMed ID: 38583639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
    Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
    Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response.
    Anderson CJ; Bredvik K; Burstein SR; Davis C; Meadows SM; Dash J; Case L; Milner TA; Kawamata H; Zuberi A; Piersigilli A; Lutz C; Manfredi G
    Acta Neuropathol; 2019 Jul; 138(1):103-121. PubMed ID: 30877432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel intracytoplasmic inclusions immunoreactive for phosphorylated-TDP43 and cystatin C in anterior horn cells in a case of sporadic amyotrophic lateral sclerosis.
    Shintaku M; Kaneda D; Oyanagi K
    Neuropathology; 2017 Dec; 37(6):526-534. PubMed ID: 28632899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients.
    Chiò A; Mora G; Sabatelli M; Caponnetto C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Monsurrò MR; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Nilo R; Battistini S; Mandrioli J; Tanel R; Murru MR; Mandich P; Zollino M; Conforti FL; ; Brunetti M; Barberis M; Restagno G; Penco S; Lunetta C
    Neurobiol Aging; 2015 Apr; 36(4):1767.e3-1767.e6. PubMed ID: 25726362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder.
    Jiang T; Wang Y; Wang X; Xu J
    Front Neurosci; 2022; 16():988265. PubMed ID: 36061599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease.
    Auranen M; Ylikallio E; Shcherbii M; Paetau A; Kiuru-Enari S; Toppila JP; Tyynismaa H
    Neurol Genet; 2015 Jun; 1(1):e1. PubMed ID: 27066538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.